Oncology Analytics
Plantation, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into Oncology Analytics
Sign up to see every warm intro you have to Oncology Analytics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncology Analytics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RW
Robert WaltonExecutive
BV
Balbino VazquezExecutive
DF
Danielle FishmanExecutive
MF
Marc FishmanNamed on SEC filing
Board
Investors · 5
Baird CapitalreportedChicago
How we know: funding news · prnewswire.com · Not right? Tell us
McKesson VenturesreportedSan Francisco
How we know: funding news · ventures.mckesson.com · Not right? Tell us
Oak HC/FTreportedStamford
How we know: funding news · prnewswire.com · Not right? Tell us
Sandbox AdvantagereportedChicago
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
The Blue Venture Fund
Reported raises · per SEC filings
Form D private placements$53.5M disclosed across 3 rounds · 2016–2020
▶$25MraisedMay 2020 · 7 investors · Other TechnologyRule 506(b)
▶$25MraisedMay 2020 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Zeke EmanuelDirector
- Marc FishmanExecutive Officer, Director
- Peter BachDirector
- Ann LamontDirector
- Thomas HawesDirector
- Michael LiangDirector
- Michael WeintraubDirector
- Rick J. DeanExecutive Officer, Director
- Offering amount
- $28M
- Amount sold
- $25M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$21MraisedNov 2018 · 4 investors · Other TechnologyRule 506(b)
▶$21MraisedNov 2018 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nick RosaDirector
- Balbino VazquezExecutive Officer, Director
- Dipa MehtaDirector
- Marc LippmanDirector
- Zeke EmanuelDirector
- Marc FishmanExecutive Officer, Director
- Thomas HawesDirector
- Rick J. DeanExecutive Officer, Director
- Ann LamontDirector
- Offering amount
- $25M
- Amount sold
- $21M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$7.5MraisedJan 2016 · 2 investors · Other Health CareRule 506(b)
▶$7.5MraisedJan 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc FishmanExecutive Officer, Director
- Marc LippmanDirector
- Nick RosaDirector
- Michael MontijoDirector
- Robert WaltonExecutive Officer
- John BradburnDirector
- Balbino VazquezExecutive Officer, Director
- Thomas HawesDirector
- Danielle FishmanExecutive Officer
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Oncology Analytics's investors?
- Oncology Analytics's investors include Baird Capital, McKesson Ventures, Oak HC/FT, Sandbox Advantage.
- How much funding has Oncology Analytics raised?
- Oncology Analytics has disclosed $53.5M raised across 3 rounds.
- Where is Oncology Analytics headquartered?
- Oncology Analytics is headquartered in Plantation, US.



